Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


What percentage of people develops Lipodystrophy? II
Jan 10, 2002

What percentage of people (on HAARt - d4t, 3tc and Sustiva) develops Lipodystrophy? Robert

Response from Dr. Henry

Many factors influence development of lipodystrophy including age, time with HIV, history of AIDS, degree of HIV control and immune recovery as well as the choice of medications and how long the meds have been used. Certainly patients on your cocktail develop lipodystrophy but differing definitions have been used so no single figure can be attached to your chances--= we don't know. Careful monitoring for lipodystrophy could pick up early trends that might respond to changes in meds or other interventions that are being studied. This topic is very important and is getting lots of attention but we still lack many answers. KH



Previous
Weight gain: any chance with diet and exercise?
Next
rash

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement